Product Images Levofloxacin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Levofloxacin NDC 55150-244 by Auromedics Pharma Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 2: Mean Levofloxacin Plasma Concentration vs. Time Profile: 750 mg - levofloxacin fig1

Figure 2: Mean Levofloxacin Plasma Concentration vs. Time Profile: 750 mg - levofloxacin fig1

The figure shows the mean plasma concentration of Levofloxacin over time after oral administration of a 750mg tablet and after a 90 minute infusion of 750mg. Concentrations are measured in micrograms per milliliter (ug/mL).*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose - Pouch (Overwrap) Label - levofloxacin fig10

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose - Pouch (Overwrap) Label - levofloxacin fig10

This is a description for Levofloxacin in 5% Dextrose Injection, which is a sterile solution for intravenous infusion. Each 150 mL bag contains 750 mg of levofloxacin (5 mg/mL) in 5% dextrose. The solution should be infused over 90 minutes, and the bag should be left in the overwrap until use. The medication guide should be given to each patient. The solution should be stored at or below 25°C and protected from light. The overwrap acts as a moisture barrier, and the solution should not be used if the container is damaged or leaks are found. For more information, see the prescribing information.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose - Carton Label - levofloxacin fig11

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose - Carton Label - levofloxacin fig11

This is a description of a medication called Levofloxacin in 5% Dextrose Injection, which comes in 24 single-use containers, each containing 150 mL of a sterile solution with 750 mg of levofloxacin dissolved in 5% dextrose. It's for intravenous infusion, to be infused over 90 minutes. The solution has a pH range of 3.8-5.8 and may contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF for pH adjustment. It should be stored at or below 25°C and protected from light and freezing. Unused portions should be discarded, and additives should not be added or infused through the same IV line. The accompanying medication guide should be given to each patient. There are also specific instructions for preparing and administering the medication, which can be found in the prescribing information. The product is distributed by AuroMedics Pharma LLC and made in India.*

Figure 3: Mean Levofloxacin Plasma Concentration vs. Time Profile: 500 mg - levofloxacin fig2

Figure 3: Mean Levofloxacin Plasma Concentration vs. Time Profile: 500 mg - levofloxacin fig2

The text describes a figure that shows the mean levofloxacin plasma concentration over time when 500 mg is administered orally and intravenously. The measurement unit for the plasma concentration is meg/mL. There is also a graph that plots the data points for the oral and intravenous administration.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose - Infusion Bag Label - levofloxacin fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose - Infusion Bag Label - levofloxacin fig3

Sme Levofloxacin in 5% Dextrose Injection is a sterile solution used for intravenous infusion. It contains 250 mg of levofloxacin in 50 mL of 5% dextrose and should be infused over 60 minutes. The solution does not require further dilution before use and each 50 mL contains a dilute solution of levofloxacin. The solution may contain Hydrochloric Acid or Sodium Hydroxide to adjust the pH. The medication guide should be dispensed to each patient and the solution should be used immediately once removed from the overwrap. The solution is for single-use containers only and any unused portion should be discarded. The usual adult dosage should be followed as per the prescribing information. The manufacturing location of this product is in India under AuroMedics Pharma LLC.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose - Pouch (Overwrap) Label - levofloxacin fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose - Pouch (Overwrap) Label - levofloxacin fig4

This is a sterile solution for intravenous infusion containing 250mg of Levofloxacin in 50 mL of 5% dextrose. It comes with a medication guide for dispensing to each patient. It can be administered for the usual adult dosage. It is stored in a single-use container, which may contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF for pH adjustment, and should be kept below 25°C (77°F) and protected from light. The overwrap on the container acts as a moisture barrier, and it should not be removed until it is ready for use. Any unused portion should be discarded, and additives should not be added or infused through the same intravenous line. It is manufactured in India by Auromedics Pharma LLC.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose - Carton Label - levofloxacin fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose - Carton Label - levofloxacin fig5

This is a sterile Levofloxacin in 5% Dextrose injection supplied in 24 single-use containers, each containing 50 mL of 250 mg Levofloxacin (5 mg/mL). It is for intravenous infusion and intended to be infused over 60 minutes. The medication guide should be dispensed to each patient. It is recommended to store this product at or below 25°C (77°F) and protect it from light and freezing. The overwrap serves as a moisture barrier and should only be removed when ready to use. After removing the overwrap, the container must be checked for minute leaks. It should be used only if the solution is clear and the container is undamaged. This medication is distributed by AuroMedics Pharma LLC in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose - Infusion Bag Label - levofloxacin fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose - Infusion Bag Label - levofloxacin fig6

Levofloxacin is a prescription drug that comes in the form of an intravenous infusion. Each 100 mL of this solution contains 500 mg of levofloxacin diluted in 5% dextrose. This solution is intended to be used immediately once removed from the overwrap, and no further dilution is needed. The infusion should be given over a 60-minute period. It is important to note that additives should not be added or infused simultaneously through the same intravenous line. This is a single-use container, and any unused portion should be discarded. This drug is manufactured in India and is intended for use under the guidance of a healthcare professional. A Medication Guide should be given to each patient with this drug.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose - Pouch (Overwrap) Label - levofloxacin fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose - Pouch (Overwrap) Label - levofloxacin fig7

This is a single-use 100 mL intravenous solution bag of Levofloxacin in 5% Dextrose Injection. The solution is sterile and contains 500 mg of Levofloxacin diluted in 5% dextrose. The recommended adult dosage can be found in the prescribing information. It should be infused intravenously over 60 minutes and the bag should be kept in overwrap until use. The accompanying medication guide must be dispensed to each patient. The recommended storage is 25°C (77°F) or below, and the product should be protected from light and freezing. The overwrap of the product is a moisture barrier, and the unit should be discarded if the container is damaged, or minute leaks are found. It should be cleared before use. See prescribing information for Preparation for Administration instructions. The product is distributed by AuroMedics Pharma LLC with the code TS/DRUGS/01/2013/LVP, and made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose - Carton Label - levofloxacin fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose - Carton Label - levofloxacin fig8

This is a single-use container of Levofloxacin in 5% Dextrose Injection for intravenous infusion. Each container holds 100 mL and contains a dilute solution equivalent to 500 mg of levofloxacin in 5% dextrose. The pharmacist should dispense the accompanying medication guide to each patient. The recommended storage temperature is at or below 25°C. The container should not be removed from the overwrap until ready to use and should be used promptly when opened. Leakage can impair sterility. See prescribing information for instructions on administration. This product is distributed by AuroMedics Pharma LLC and made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose - Infusion Bag Label - levofloxacin fig9

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose - Infusion Bag Label - levofloxacin fig9

This is a sterile, prescription-only Levofloxacin in 5% Dextrose Injection with 750mg of Levofloxacin (5mg/mL) in a 150mL container. It is meant to be used only for intravenous infusion and should be used immediately after removal from the overwrap. The container should not be damaged and the solution should be clear before use. It contains a dilute solution equivalent of 750mg of levofloxacin (5mg/mL) in 5% Dextrose, with a pH of 3.8-5.8. The container is for single-use only and any unused portion should be discarded. The accompanying Medication Guide should be dispensed to each patient. Usual Adult Dosage is provided in prescribing information. The product is manufactured in India for AuroMedics Pharma LLC in New Jersey, USA.*

Chemical Structure - levofloxacin str

Chemical Structure - levofloxacin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.